Patients & Volunteers Information for those interested or currently participating in a clinical trial
	Research Sponsors Why you should choose Aurora for your clinical trials
	Investigators & Coordinators Learn more about our services
	Research Matters Quarterly newsletter about research at Aurora
	Links Learn more about clinical research
	Contact us Contact the Clinical Research department
	Return home Return to the Clinical Research home page

Select from the search options to widen or narrow the search results.

Prostate Cancer Study (RTOG0518)

The purpose of this study is to compare the effects, good and/or bad, of a drug, 

zoledronic acid plus vitamin D and a calcium supplement, with vitamin D 

and a calcium supplement alone.  This study is being done to find out if zoledronic acid prevents bone fractures

by strengthening bones better than vitamin D and calcium alone.

 To participate in this study you must:

• Have been diagnosed with high-grade and/or locally advanced prostate cancer within the last 12 months

• Plan to receive radiation therapy or have begun radiation therapy within the last 8 weeks

• Receive hormone therapy as a part of your treatment

For more information please contact: Kerri Cwiklinski, RN at 414-649-5084 or 

kerri.cwiklinski@aurora.org

Principal Investigator:  Rakesh Jagetia, MD 

Clinical trial location(s)

West Allis Memorial Hospital
8901 West Lincoln Avenue
West Allis, WI 53227

[ previous page ]

Copyright Aurora Health Care, a not-for-profit health care provider serving Wisconsin.
3000 W. Montana St., Milwaukee, WI 53215, (414) 647-3000
Disclaimer | Privacy notice | Contact us
.